Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ultragenyx Pharmaceutical Inc. - Common Stock
(NQ:
RARE
)
31.04
-10.40 (-25.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ultragenyx Pharmaceutical Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Breaking Down Ultragenyx Pharmaceutical: 4 Analysts Share Their Views
Today 18:00 EDT
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
Today 15:00 EDT
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Today 13:05 EDT
Via
Benzinga
Crude Oil Down Over 2%; Delta Air Lines Posts Upbeat Earnings
Today 13:04 EDT
Via
Benzinga
What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
May 28, 2025
Via
Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
Via
Benzinga
Ultragenyx Pharmaceutical's Earnings: A Preview
May 05, 2025
Via
Benzinga
Breaking Down Ultragenyx Pharmaceutical: 7 Analysts Share Their Views
February 14, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Thursday?
Today 12:30 EDT
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
US Stocks Mixed; Initial Jobless Claims Fall
Today 10:46 EDT
Via
Benzinga
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease
Today 10:31 EDT
The study will continue onto a third and final analysis toward the end of the year.
Via
Investor's Business Daily
Thursday's session: gap up and gap down stocks
Today 10:30 EDT
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Breaking Down Ultragenyx Pharmaceutical: 11 Analysts Share Their Views
January 22, 2025
Via
Benzinga
Expert Outlook: Ultragenyx Pharmaceutical Through The Eyes Of 11 Analysts
December 20, 2024
Via
Benzinga
Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win
Today 10:06 EDT
Ultragenyx shares fall after Phase 3 study misses interim target, but analysts remain positive ahead of final OI data expected later this year.
Via
Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
Today 8:30 EDT
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Today 8:09 EDT
Via
Benzinga
Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Today 8:00 EDT
Via
Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
Today 5:47 EDT
Via
Benzinga
Ultragenyx, Mereo Sink After Hours As Bone Drug Trial Continues Without Early Stop; Retail Traders Feel Selloff Is Overdone
Today 0:38 EDT
The companies now expect final data from the Orbit and Cosmic studies by the end of the year.
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 09, 2025
Via
Benzinga
What's going on in today's after hours session
July 09, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Ultragenyx Pharmaceutical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
June 20, 2025
Via
Benzinga
Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028
May 28, 2025
Ultragenyx sees rising revenue and analyst support as key drug launch approaches, with potential profitability projected for 2027.
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
May 01, 2025
Via
Benzinga
Ultragenyx Stays On JPMorgan's Focus List As Analyst Highlights Strong Long-Term Positioning
March 27, 2025
JP Morgan sees strong upside for Ultragenyx, citing setrusumab trial progress and pipeline growth, raising the price target to $117.
Via
Benzinga
Demystifying Ultragenyx Pharmaceutical: Insights From 10 Analyst Reviews
March 17, 2025
Via
Benzinga
Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside
January 15, 2025
Ultragenyx forecasts 2024 revenue above estimates, highlights confidence in setrusumab trial progress, and outlines plans for regulatory filings in 2025.
Via
Benzinga
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
January 03, 2025
William Blair starts coverage on Denali Therapeutics with an Outperform rating, citing its transport vehicle platform and promising therapies for neurodegenerative diseases.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.